Atlas Trials

Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer

Clinical trial NCT07537361 · RECRUITING

Trial details

NCT number
NCT07537361
Sponsor
Qilu Hospital of Shandong University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerLeucine-restricted Diet
Start date
2026-01-01
Primary completion
2027-06-30
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.